7VI4 image
Deposition Date 2021-09-24
Release Date 2022-09-28
Last Version Date 2024-06-19
Entry Detail
PDB ID:
7VI4
Keywords:
Title:
Electron crystallographic structure of TIA-1 prion-like domain, A381T mutant
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
0.95 Å
R-Value Free:
0.30
R-Value Work:
0.24
R-Value Observed:
0.25
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:TIA-1 prion-like domain
Gene (Uniprot):TIA1
Mutations:A381T
Chain IDs:A
Chain Length:10
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
ALS mutations in the TIA-1 prion-like domain trigger highly condensed pathogenic structures.
Proc.Natl.Acad.Sci.USA 119 e2122523119 e2122523119 (2022)
PMID: 36112647 DOI: 10.1073/pnas.2122523119

Abstact

T cell intracellular antigen-1 (TIA-1) plays a central role in stress granule (SG) formation by self-assembly via the prion-like domain (PLD). In the TIA-1 PLD, amino acid mutations associated with neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) or Welander distal myopathy (WDM), have been identified. However, how these mutations affect PLD self-assembly properties has remained elusive. In this study, we uncovered the implicit pathogenic structures caused by the mutations. NMR analysis indicated that the dynamic structures of the PLD are synergistically determined by the physicochemical properties of amino acids in units of five residues. Molecular dynamics simulations and three-dimensional electron crystallography, together with biochemical assays, revealed that the WDM mutation E384K attenuated the sticky properties, whereas the ALS mutations P362L and A381T enhanced the self-assembly by inducing β-sheet interactions and highly condensed assembly, respectively. These results suggest that the P362L and A381T mutations increase the likelihood of irreversible amyloid fibrillization after phase-separated droplet formation, and this process may lead to pathogenicity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures